Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Sunday 05.04.2020 at 10:00 AM CEST
Settings

Settings

1. WO2000038663 - EP¿4? RECEPTOR AGONISTS FOR TREATMENT OF DRY EYE

Publication Number WO/2000/038663
Publication Date 06.07.2000
International Application No. PCT/US1999/029734
International Filing Date 14.12.1999
Chapter 2 Demand Filed 14.06.2000
IPC
A61K 31/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
A61K 31/5575 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
557Eicosanoids, e.g. leukotrienes
5575having a cyclopentane ring, e.g. prostaglandin E2, prostaglandin F2-alpha
CPC
A61K 31/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
A61K 31/5575
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
557Eicosanoids, e.g. leukotrienes ; or prostaglandins
5575having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
A61K 31/5585
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
557Eicosanoids, e.g. leukotrienes ; or prostaglandins
558having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
5585having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
A61K 31/559
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
557Eicosanoids, e.g. leukotrienes ; or prostaglandins
559having heterocyclic rings containing hetero atoms other than oxygen
Y10S 514/912
YSECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
10TECHNICAL SUBJECTS COVERED BY FORMER USPC
STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
514Drug, bio-affecting and body treating compositions
912Ophthalmic
Applicants
  • ALCON LABORATORIES, INC. [US/US]; 6201 South Freeway Fort Worth, TX 76134-2099, US (AT, AU, BE, BR, CA, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, JP, LU, MC, MX, NL, PT, SE)
  • SHARIF, Najam, A. [GB/GB]; US (UsOnly)
Inventors
  • SHARIF, Najam, A.; US
Agents
  • COPELAND, Barry, L. ; Alcon Laboratories, Inc. 6201 South Freeway Fort Worth, TX 76134-2099, US
Priority Data
60/113,69824.12.1998US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) EP4 RECEPTOR AGONISTS FOR TREATMENT OF DRY EYE
(FR) AGONISTES DU RECEPTEUR EP4 UTILISES DANS LE TRAITEMENT DU SYNDROME SEC
Abstract
(EN)
Compositions and methods for the treatment of dry eye and related diseases utilizing EP4 receptor agonists are disclosed.
(FR)
La présente invention concerne des compositions et des méthodes de traitement du syndrome sec et des maladies liées à cet état pathologique, à l'aide d'agonistes du récepteurs EP4.
Also published as
US09462737
Latest bibliographic data on file with the International Bureau